Now available on demand! Optimizing clinical development plans requires trade-offs across competing factors. Join us for an expert panel discussion exploring how coupling innovative development strategies with analytical tools can drive better drug development decisions.
As competition in the biopharmaceutical industry increases, firms must make effective drug development trade-off decisions considering risk, timing and cost. This requires collaboration across functions, informed forecasts, and, ideally, comparison of multiple options.
Please join us for a webinar discussing these trade-offs and how companies can work in a cross-functional way to achieve effective scenario planning. Learn about the common dynamics that development teams need to evaluate, and how to build scenario comparisons to choose the best path forward. Hear from drug development experts about the different types of trade-offs in clinical development planning, and how to use real-world evidence and adaptive trial designs to supercharge decision-making. We will also showcase a technology platform for optimizing clinical development scenario planning.
Speakers Name and Title:
Rick Johnston, PhD
Senior Software Solutions Lead
Dr. Johnston is the Senior Software Solutions Lead within IQVIA's Consulting Organization. He is an accomplished technical leader with more than 15 years’ experience in building software that solves big data, machine learning and advanced analytics problems in pharma. Software built by Dr. Johnston is used by more than 90% of the world’s 25 largest pharmaceutical companies. He has a Ph.D. in operations research and bioinformatics from UC Berkeley.
VP, Consulting Services
David Wolter is a Vice President of IQVIA’s Consulting Services group. He has more than 15 years of experience in management consulting and modeling system development and is the lead of the US Strategy & Portfolio Analysis Solution Team. His past work has included product valuations, detailed forecasting exercises, analogue analyses, and decision-analysis/strategy projects – both with and without the support of software tools. David has an MBA from Stanford GSB, an MS in Accounting from DePaul University and a BA in Economics from Amherst College.
Times and Date: